Orthotopic heart transplantation with reconstruction of persistent left superior vena cava

Kazuma Handa1, Hiroki Hata2, Koichi Toda1

  • 1Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.

Surgical Case Reports
|April 17, 2020
PubMed

Insights

Persistent left superior vena cava (PLSVC) can be managed during heart transplantation. Reconstruction using a prosthetic graft offers a viable option for PLSVC, ensuring successful outcomes in heart transplant recipients.

Area of Science:

  • Cardiovascular Surgery
  • Congenital Vascular Abnormalities
  • Transplantation Medicine

Background:

  • Persistent left superior vena cava (PLSVC) is a common congenital vascular anomaly.
  • This anomaly presents unique challenges during cardiac procedures, including heart transplantation.

Purpose of the Study:

  • To describe a novel surgical technique for managing PLSVC during orthotopic heart transplantation.
  • To evaluate the efficacy and safety of using a prosthetic vascular graft for PLSVC reconstruction.

Main Methods:

  • A case report of a 20-year-old male with idiopathic dilated cardiomyopathy and PLSVC undergoing heart transplantation.
  • Reconstruction of the transected PLSVC using a prosthetic vascular graft anastomosed to the right atrium.
  • Postoperative assessment using enhanced computed tomography to confirm graft patency.

Main Results:

  • The prosthetic graft demonstrated good patency on postoperative imaging.
  • The patient experienced an uneventful postoperative course with a 2-year follow-up.
  • No major complications related to the PLSVC reconstruction were observed.

Conclusions:

  • Prosthetic graft reconstruction is a feasible and effective option for managing PLSVC during heart transplantation.
  • This technique may help mitigate risks associated with PLSVC in transplant recipients.
Abstract

Related Concept Videos